Pharmaco - Press Releases

Date	Title	Company
21-Jul-2023	HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study	HUTCHMED
21-Jul-2023	Healthcasts Introduces ConsensusAI, the First AI-Powered, Real-Time Patient Consultation Tool for Healthcare Professionals	Healthcasts
21-Jul-2023	Lonza Delivers 5.6% CER Sales Growth, With Underlying Growth at Around 10% CER and 30% CORE EBITDA Margin	Lonza Group AG
21-Jul-2023	Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech	Sartorius Stedim Biotech SA
20-Jul-2023	Cantourage Group SE continues profitable growth course in first half of 2023	Cantourage Group SE
20-Jul-2023	Accelerated patient recruitment; adapted study protocol meets expectations for human clinical trial of breakthrough silver antibacterial coating technology	aap Implantate AG
20-Jul-2023	Biophytis: Biophytis has requested a pre-submission meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the treatment of COVID-19	Biophytis
19-Jul-2023	Biophytis Announces $3.8 Million Registered Direct Offering	Biophytis
19-Jul-2023	Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec Health	Relief Therapeutics Holding SA
18-Jul-2023	STRATEC POSTS PRELIMINARY RESULTS FOR FIRST HALF AND ADJUSTS GUIDANCE FOR 2023 FINANCIAL YEAR	STRATEC SE
18-Jul-2023	Sartorius Stedim Biotech SA: Sartorius Stedim Biotech completes acquisition of Polyplus	Sartorius Stedim Biotech SA
18-Jul-2023	Original-Research: Spexis AG (von First Berlin Equity Research GmbH)	Spexis AG
18-Jul-2023	WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturing Line at Wuxi City Site	WuXi STA
18-Jul-2023	Mainz Biomed Announces Collaboration with Fugene Genetics in Israel	Mainz BioMed N.V.
18-Jul-2023	Defence Therapeutics Inc.: DEFENCE SUCCESSFULLY COMPLETES THE FIRST MILESTONE OF ITS COLLABORATION AGREEMENT WITH ORANO	Defence Therapeutics Inc.
18-Jul-2023	US and LATAM businesses continue with double-digit growth; Q2 sales increase of +8%; solid growth of +6% in H1/2023	aap Implantate AG
18-Jul-2023	Biophytis and SEQENS sign a partnership to produce Sarconeos (BIO101) active compound	Biophytis
18-Jul-2023	Genomic Vision Launches HexaCard, a New Service to Characterize Cell Lines Used for Biomanufacturing and Cell & Gene Therapy	B3C newswire
17-Jul-2023	Santen launches Roclanda®, with the ROCK inhibitor netarsudil, in the UK – representing the first new class of medication for the medical management of glaucoma in Europe in 25 years	Santen
17-Jul-2023	Cannovum Cannabis AG: New partner strengthens offer for private cultivation of cannabis	Cannovum Cannabis AG